An in vitro study indicated that GLP1-RA liraglutide suppressed CRC migration and survival, inducing apoptotic cell death through inhibition of the PI3K/Akt/mTOR pathway [189]. The gene discussed is GLP1R; the disease is colorectal carcinoma.